Although COVID-19 is now a communicable illness under observation, the health ministry nevertheless recommends vaccination. This is especially true for vaccine booster doses. Meanwhile, 6 to 4-year-olds will start being vaccinated on October 12.
Opas Karnkawinpong, permanent secretary of the Public Health Ministry of Thailand, convened the conference to discuss the administration of the COVID-19 vaccination to children between the ages of 6 months and 4 years. Officials from health departments all throughout the country were there.
The conference was scheduled to guarantee that the October 12 immunization schedule for young children will go off without a hitch. Minister of Public Health Anutin Charnvirakul presided over the meeting, which took place in the conference room at Phra Nang Klao hospital in Nonthaburi.
The vaccination must come in the dark red caps made by Pfizer. Following validation by the Division of Medical Sciences, the vaccination vials will be distributed to local health departments. Dr. Tares Krassanairawiwong, interim head of the Department of Disease Control (DDC), has reported that many parents have given their approval for their young children to get vaccinated. The Pfizer vaccine with the black cap, he said, can be given to a youngster together with others.
Dr. Sopon Iamsirithaworn found that infant and toddler mortality was three times that of school-aged children. Vaccinating infants and toddlers is an effective strategy for reducing the incidence rate. The vaccination dosage for each child will be 3 micrograms, and they will receive a total of 3 doses. Adults should take 30 micrograms, while kids 5-11 should take 10 micrograms. As instructed, the second dosage will be given one month after the first, and the third dose will be given two months after the second.
According to Dr. Wanatpreeya Phongsamart, the chief of the pediatric infectious diseases branch at Siriraj Hospital, immunizations have been shown to be 80% effective at avoiding Omicron in young infants in the United States. When compared to older children, there have been no reports of significant adverse effects or inflammation of the heart muscle. Redness and discomfort may flare up in certain areas, she said.